Abstral

Abstral is a sublingual fentanyl medication used for managing breakthrough pain in adults already on opioid therapy. This fast-acting formulation is designed for rapid relief.

Abstral is primarily used for the treatment of breakthrough pain in adults who are already receiving opioid therapy for chronic pain. Breakthrough pain is a sudden flare-up of pain that occurs despite regular pain management. The sublingual formulation allows for quick absorption, providing rapid relief. Patients should consult their healthcare provider to determine if Abstral is suitable for their specific pain management needs.

Common effects of Abstral may include drowsiness, dizziness, nausea, and headache. Some users may experience constipation or dry mouth. These effects can vary from person to person and may subside as the body adjusts to the medication.

Abstral should be handled with care, as it contains a potent opioid. It is important to store the medication securely to prevent misuse. Patients should avoid activities that require alertness, such as driving or operating machinery, until they know how Abstral affects them. Always follow the guidance of a healthcare professional when using this medication.

Abstral may interact with other medications, including alcohol, sedatives, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Combining Abstral with other central nervous system depressants can increase the risk of severe side effects.